hydrogen sulfide has been researched along with levodopa in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Del Soldato, P; Giustarini, D; Lee, M; McGeer, E; McGeer, PL; Rossi, R; Sparatore, A; Tazzari, V | 1 |
Savolainen, H | 1 |
Bian, JS; Del Soldato, P; Liu, YY; Sparatore, A | 1 |
Del Soldato, P; Giustarini, D; Rossi, R; Santus, G; Sparatore, A | 1 |
Olas, B | 1 |
2 review(s) available for hydrogen sulfide and levodopa
Article | Year |
---|---|
Therapeutic potential of new hydrogen sulfide-releasing hybrids.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Humans; Hydrogen Sulfide; Inflammation; Latanoprost; Levodopa; Prodrugs; Prostaglandins F, Synthetic | 2011 |
Medical Functions of Hydrogen Sulfide.
Topics: Angiogenesis Inducing Agents; Cardiovascular Agents; Cysteine; Diclofenac; Disulfides; Heart; Humans; Hydrogen Sulfide; Kidney; Levodopa; Prostaglandins F, Synthetic; Reperfusion Injury; Sulfides; Thioctic Acid; Thiones; Vasodilator Agents | 2016 |
3 other study(ies) available for hydrogen sulfide and levodopa
Article | Year |
---|---|
Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease.
Topics: Animals; Cell Line; Cell Line, Tumor; Humans; Hydrogen Sulfide; Interleukin-6; Levodopa; Mitochondria; Models, Biological; Neuroglia; Neuroprotective Agents; Nitric Oxide; Parkinson Disease; Rats; Tumor Necrosis Factor-alpha | 2010 |
High toxicity of hydrogen sulfide by the inhibition of mitochondrial respiration.
Topics: Animals; Antioxidants; Cell Respiration; Dopamine; Electron Transport Complex IV; gamma-Aminobutyric Acid; Hydrogen Sulfide; Levodopa; Lipid Peroxidation; Mitochondria; Neuroglia; Rats | 2010 |
ACS84, a novel hydrogen sulfide-releasing compound, protects against amyloid β-induced cell cytotoxicity.
Topics: Amyloid beta-Peptides; Animals; Animals, Newborn; Cells, Cultured; Disulfides; Dose-Response Relationship, Drug; Hydrogen Sulfide; Levodopa; Neurons; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2011 |